cadmium has been researched along with mdl 100907 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrade, R; Beique, JC; Gingrich, JA; Villalobos, C | 1 |
Alexandropoulou, KN; Demonakou, MD; Hereti, RI; Kourentzi, KT; Manta, GA; Mykoniatis, MG; Panoutsopoulos, GI; Papadimas, GK; Skaltsas, SD; Tzirogiannis, KN | 1 |
2 other study(ies) available for cadmium and mdl 100907
Article | Year |
---|---|
Serotonergic regulation of calcium-activated potassium currents in rodent prefrontal cortex.
Topics: Animals; Animals, Newborn; Cadmium; Calcium Channel Blockers; Drug Interactions; Fluorobenzenes; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurons; Piperidines; Potassium Channels, Calcium-Activated; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 2005 |
Effect of 5-HT(2) receptor blockade on cadmium-induced acute toxicity.
Topics: Animals; Apoptosis; Cadmium; Disease Models, Animal; In Situ Nick-End Labeling; Ketanserin; Liver Failure, Acute; Male; Rats; Rats, Wistar; Receptors, Serotonin, 5-HT2; Ritanserin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Treatment Outcome | 2007 |